FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...

Canada’s Top Growing Companies: Provinces

Report on Business magazine’s ranking of Canada’s Top Growing Companies lists qualifying independent Canadian companies by the percentage of their revenue growth over three years. The provincial ...

The simple résumé template a career expert recommends for the AI era

Amy Perrotta, the founder of a career branding company, says an effective résumé makes a recruiter "want to pick up the phone ...